Deconstructing the Pipeline: Using Efficacy, Effectiveness ...

There is also evidence of efficacy against severe illness, although the estimate is imprecise due to the lower number of people overall who developed severe disease (VE 88.9% after first dose [95% CI: 20.1–99.7]).37 In a preprint analysis of a population level prospective cohort study in Scotland, vaccine effectiveness against hospitalisation ... ................
................